Ryder Capital Boosts Stake in Lumos Diagnostics
Company Announcements

Ryder Capital Boosts Stake in Lumos Diagnostics

Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.

Ryder Capital Limited & Associated Entities, a substantial shareholder in Lumos Diagnostics Holdings Ltd., has increased its voting power from 7.17% to 8.31% through on-market purchases. The transactions took place on September 20, 2024, with the acquisition of an additional 6.4 million ordinary shares for a total consideration of approximately $198,400. This change in holdings signifies a notable rise in Ryder Capital’s influence over the company.

For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App